ACE-031 in Pre-Clinical Myostatin Blockade and Muscle Growth Studies
Researchers employ ACE-031 to investigate its high-affinity binding to myostatin (GDF-8) and activin A, thereby blocking their interaction with activin type II receptors and attenuating Smad2/3 activation. Pre-clinical observations in rodent and nonhuman primate models indicate dose-dependent increases in lean muscle mass, enhanced myofiber hypertrophy, and improved functional strength following administration.
This fusion protein enables detailed examination of negative regulation release on skeletal muscle growth, muscle-bone coupling, and regenerative responses in injury or deficiency research paradigms.
Scientific Overview of ACE-031 Applications
Pre-clinical models demonstrate ACE-031’s sequestration of TGF-β family ligands:
- High-affinity binding to myostatin and activin, preventing ActRIIB receptor activation and Smad signaling to promote skeletal muscle hypertrophy in rodent systems.
- Enhancement of muscle mass and strength through inhibition of myostatin-mediated suppression of myoblast proliferation and differentiation.
- Modulation of bone formation and fracture healing dynamics, with increased callus size and bone volume observed in deficiency or antagonism models.
- Support for investigations into muscle regeneration and functional recovery in injury paradigms via blockade of TGF-β signaling.
- Influence on metabolic parameters, including reduced adiposity and improved insulin sensitivity in obesity-linked research contexts.
- Examination of muscle-bone interactions and coordinated regenerative responses in multi-species models.
For further details on TGF-β superfamily antagonists, myostatin inhibition, and musculoskeletal signaling in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.
Commitment to Research-Grade Quality at National Science Labs
National Science Labs produces ACE-031 under rigorous GMP-compliant protocols to deliver batch-to-batch consistency and reliability for pre-clinical experiments. Each lot undergoes independent third-party analysis, confirming:
- Purity ≥99% by HPLC and SEC
- Structural identity and glycosylation profile verification
- Comprehensive Certificate of Analysis (CoA) available for download per batch
For Research Use Only. This product is supplied exclusively for in vitro and in vivo pre-clinical research by qualified investigators. Statements regarding this peptide have not been evaluated by the FDA.
Initiate Your Myostatin Inhibition Research
Secure high-purity ACE-031 from current limited batches to maintain optimal stability and performance in your muscle growth and regeneration studies.
